adenine has been researched along with Dermatitis Medicamentosa in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lamivudine is widely used for the treatment of chronic hepatitis B infection because of it's remarkable antiviral efficacy and safety." | 7.73 | [A case of severe skin eruption caused by lamivudine in a patient with chronic hepatitis B]. ( Baik, du S; Kim, BH; Kim, HJ; Kim, SB; Seo, PJ; Shin, JE; Song, IH; Yun, SY, 2006) |
| "Nevirapine treatment was stopped and was substituted with efavirenz: the patient continued on therapy with tenofovir and lamivudine." | 5.38 | Hyperhidrosis related to nevirapine therapy. ( Belda, A; Borrás-Blasco, J; Casterá, E; Jiménez, I; López-Montes, L; Rosique-Robles, D, 2012) |
| "Lamivudine is widely used for the treatment of chronic hepatitis B infection because of it's remarkable antiviral efficacy and safety." | 3.73 | [A case of severe skin eruption caused by lamivudine in a patient with chronic hepatitis B]. ( Baik, du S; Kim, BH; Kim, HJ; Kim, SB; Seo, PJ; Shin, JE; Song, IH; Yun, SY, 2006) |
| " Most common adverse events (AEs) leading to prior KI discontinuation were rash (27%), arthralgia (18%), and atrial fibrillation (16%)." | 3.01 | Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy. ( Barr, PM; Barrientos, JC; Brander, DM; Cheson, BD; Dorsey, C; Flinn, IW; Fonseca, GA; Ghosh, N; Hamadeh, IS; Kambhampati, S; Lamanna, N; Lansigan, F; LaRatta, N; Luning Prak, ET; Mato, AR; Miskin, HP; Pagel, JM; Paskalis, D; Pu, JJ; Rai, KR; Reeves, JA; Roeker, L; Schuster, SJ; Sitlinger, A; Skarbnik, AP; Sportelli, P; Svoboda, J; Tsao, P; Weiss, MS; Weissbrot, H, 2021) |
| "Objective An open-label, three-period pharmacokinetic study was conducted to investigate the drug interaction potential between fosamprenavir (FPV) and tenofovir disoproxil fumarate (TDF)." | 2.75 | Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers. ( Andrews, M; Condoluci, DV; Luber, AD; Olson, K; Pakes, GE; Pappa, KA; Peloquin, CA; Slowinski, PD, 2010) |
| "A 70-year-old white man with stage C chronic lymphocytic leukemia who was being successfully treated with ibrutinib and rituximab developed bilateral, purpuric, painful cutaneous nodules." | 1.43 | Cutaneous, Purpuric Painful Nodules Upon Addition of Ibrutinib to RCVP Therapy in a CLL Patient: A Distinctive Reaction Pattern Reflecting Iatrogenic Th2 to Th1 Milieu Reversal. ( Magro, CM; Mulvey, JJ; Nuovo, GJ, 2016) |
| "Nevirapine treatment was stopped and was substituted with efavirenz: the patient continued on therapy with tenofovir and lamivudine." | 1.38 | Hyperhidrosis related to nevirapine therapy. ( Belda, A; Borrás-Blasco, J; Casterá, E; Jiménez, I; López-Montes, L; Rosique-Robles, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 6 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomquist, MS | 1 |
| Curry, JL | 1 |
| Krishnan, B | 1 |
| Rivero, G | 1 |
| Curry, CV | 1 |
| Diwan, AH | 1 |
| Truong, K | 1 |
| Bhattacharyya, A | 1 |
| Kim, J | 1 |
| Wells, J | 1 |
| Sibaud, V | 1 |
| Beylot-Barry, M | 1 |
| Protin, C | 1 |
| Vigarios, E | 1 |
| Recher, C | 1 |
| Ysebaert, L | 1 |
| Marcaillou, M | 1 |
| Stéphanie, D | 1 |
| Marion, B | 1 |
| Julien, S | 1 |
| Christophe, B | 1 |
| Mato, AR | 1 |
| Ghosh, N | 1 |
| Schuster, SJ | 1 |
| Lamanna, N | 1 |
| Pagel, JM | 1 |
| Flinn, IW | 1 |
| Barrientos, JC | 1 |
| Rai, KR | 1 |
| Reeves, JA | 1 |
| Cheson, BD | 1 |
| Barr, PM | 1 |
| Kambhampati, S | 1 |
| Lansigan, F | 1 |
| Pu, JJ | 1 |
| Skarbnik, AP | 1 |
| Roeker, L | 1 |
| Fonseca, GA | 1 |
| Sitlinger, A | 1 |
| Hamadeh, IS | 1 |
| Dorsey, C | 1 |
| LaRatta, N | 1 |
| Weissbrot, H | 1 |
| Luning Prak, ET | 1 |
| Tsao, P | 1 |
| Paskalis, D | 1 |
| Sportelli, P | 1 |
| Miskin, HP | 1 |
| Weiss, MS | 1 |
| Svoboda, J | 1 |
| Brander, DM | 1 |
| Gribben, JG | 1 |
| Bosch, F | 1 |
| Cymbalista, F | 1 |
| Geisler, CH | 1 |
| Ghia, P | 1 |
| Hillmen, P | 1 |
| Moreno, C | 1 |
| Stilgenbauer, S | 1 |
| El Halabi, L | 1 |
| Cherif-Rebai, K | 1 |
| Michot, JM | 1 |
| Ghez, D | 1 |
| Giovanni, B | 1 |
| Ibatici, A | 1 |
| Sola, S | 1 |
| Brunasso, AMG | 1 |
| Massone, C | 1 |
| Bayonne Kombo, ES | 1 |
| Gathse, A | 1 |
| Mulvey, JJ | 1 |
| Nuovo, GJ | 1 |
| Magro, CM | 1 |
| Luber, AD | 1 |
| Condoluci, DV | 1 |
| Slowinski, PD | 1 |
| Andrews, M | 1 |
| Olson, K | 1 |
| Peloquin, CA | 1 |
| Pappa, KA | 1 |
| Pakes, GE | 1 |
| Belda, A | 1 |
| Borrás-Blasco, J | 1 |
| Rosique-Robles, D | 1 |
| Jiménez, I | 1 |
| López-Montes, L | 1 |
| Casterá, E | 1 |
| Woolley, IJ | 1 |
| Veitch, AJ | 1 |
| Harangozo, CS | 1 |
| Moyle, M | 1 |
| Korman, TM | 1 |
| Kim, SB | 1 |
| Seo, PJ | 1 |
| Baik, du S | 1 |
| Yun, SY | 1 |
| Kim, BH | 1 |
| Shin, JE | 1 |
| Kim, HJ | 1 |
| Song, IH | 1 |
| Lockhart, SM | 1 |
| Rathbun, RC | 1 |
| Stephens, JR | 1 |
| Baker, DL | 1 |
| Drevets, DA | 1 |
| Greenfield, RA | 1 |
| Salvaggio, MR | 1 |
| Vincent, S | 1 |
| Hyndiuk, RA | 1 |
| Hull, DS | 1 |
| Schultz, RO | 1 |
| Chin, GN | 1 |
2 reviews available for adenine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors.
Topics: Adenine; Administration, Cutaneous; Agammaglobulinaemia Tyrosine Kinase; Benzamides; Biopsy; Drug Er | 2020 |
Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice.
Topics: Adenine; Anticoagulants; Antineoplastic Agents; Arthralgia; Atrial Fibrillation; Diabetes Mellitus, | 2018 |
2 trials available for adenine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antineoplastic Agents; Cardio | 2021 |
Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers.
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Carbamates; Cross-Over Studies; Drug Administrati | 2010 |
12 other studies available for adenine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Ibrutinib skin toxicities: Report of two cases.
Topics: Adenine; Aged; Drug Eruptions; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cel | 2022 |
A uniquely distributed purpuric drug eruption from acalabrutinib.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Benzamides; Drug Eruptions; Humans; Piperidines; Prote | 2022 |
Atypical Painful Purpuric Cutaneous Nodules With Ibrutinib.
Topics: Adenine; Aged; Antineoplastic Agents; Drug Eruptions; Humans; Leukemia, Lymphocytic, Chronic, B-Cell | 2020 |
Ibrutinib-Induced Neutrophilic Dermatosis.
Topics: Adenine; Antineoplastic Agents; Chromosomes, Human, Pair 17; Drug Eruptions; Female; Humans; Leukemi | 2018 |
Ibrutinib and Pyoderma Gangrenosum in a Patient With B-Cell Chronic Lymphocytic Leukemia.
Topics: Adenine; Antineoplastic Agents; Drug Eruptions; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 2020 |
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asthenia; Benzoxazi | 2013 |
Cutaneous, Purpuric Painful Nodules Upon Addition of Ibrutinib to RCVP Therapy in a CLL Patient: A Distinctive Reaction Pattern Reflecting Iatrogenic Th2 to Th1 Milieu Reversal.
Topics: Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Bio | 2016 |
Hyperhidrosis related to nevirapine therapy.
Topics: Adenine; Aged; Anti-HIV Agents; Drug Eruptions; HIV Seropositivity; Humans; Hyperhidrosis; Lamivudin | 2012 |
Lichenoid drug eruption to tenofovir in an HIV/hepatitis B virus co-infected patient.
Topics: Adenine; Anti-HIV Agents; Drug Eruptions; Hepatitis B, Chronic; HIV Infections; Humans; Lichenoid Er | 2004 |
[A case of severe skin eruption caused by lamivudine in a patient with chronic hepatitis B].
Topics: Adenine; Antiviral Agents; Drug Eruptions; Female; Hepatitis B, Chronic; Humans; Ichthyosis; Lamivud | 2006 |
Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases.
Topics: Adenine; Adult; Drug Eruptions; Drug Therapy, Combination; Exanthema; Female; HIV Infections; HIV Pr | 2007 |
Adenine arabinoside in idoxuridine unresponsive and intolerant herpetic keratitis.
Topics: Adenine; Administration, Topical; Anti-Inflammatory Agents; Antiviral Agents; Arabinose; Drug Erupti | 1975 |